Zobrazeno 1 - 10
of 79
pro vyhledávání: '"K K, Hampton"'
Autor:
M. Jansen, K. K. Hampton, Anna Klukowska, Savita Rangarajan, Craig M. Kessler, C. R. M. Hay, Sigurd Knaub, M. von Depka, Johann Bichler, Nadezhda Zozulya
Publikováno v:
Haemophilia. 24:70-76
Introduction Haemophilia A patients are at a high risk of excess bleeding during surgeries. The aim of haemostatic therapy during the perioperative period is to normalize FVIII level perioperatively and postoperatively to maintain normal haemostasis
Autor:
Katharina Holstein, Edward G. D. Tuddenham, Charles R. M. Hay, Sigurd Knaub, M. von Depka, Johann Bichler, Ingrid Pabinger, K. K. Hampton, Johannes Oldenburg, Angela Huth-Kühne, Savita Rangarajan, Toshko Lissitchkov
Publikováno v:
Haemophilia. 22:225-231
Introduction Nuwiq® [human cell line-derived recombinant factor VIII (human-cl rhFVIII)] is a new generation rFVIII protein, without chemical modification or fusion to any other protein, produced in a human cell line. Aim/methods This prospective, o
Publikováno v:
Haemophilia. 20:587-592
Summary Major surgery in persons with haemophilia A and inhibitors is increasingly being performed. Both recombinant activated factor VII (rFVIIa) and activated prothrombin complex concentrate (APCC) are used to cover surgery but it remains unclear w
Autor:
K. K. Hampton
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 2
Autor:
Peter Toth, Stuart Laidlaw, Rhona Maclean, Michael Makris, K. K. Hampton, Steve Kitchen, Joost J. van Veen
Publikováno v:
Blood Coagulation & Fibrinolysis. 22:565-570
Low molecular weight heparins (LMWHs) are frequently used in the prophylaxis or treatment of venous thrombosis, acute coronary syndromes and peri-operative bridging. Major bleeding occurs in 1-4% depending on dose and underlying condition. Protamine
Autor:
Steve Kitchen, J. M. Smith, Anita M. Woolley, Michael Makris, Annette E. Bowyer, Rhona Maclean, K. K. Hampton, J. J. Van Veen
Publikováno v:
International Journal of Laboratory Hematology. 33:212-218
Summary Introduction: An isolated prolongation to the activated partial thromboplastin time (APTT) can be caused by the presence of the lupus anticoagulant or an intrinsic or contact factor deficiency, of which only deficiencies of factors VIII, IX o
Autor:
N Shaw, J P Ng, K. K. Hampton, W S A Smellie, R Bowlees, S M Mackenzie, J Hoffman, S C Martin, C. Van Heyningen
Publikováno v:
Journal of Clinical Pathology. 60:740-748
This eighth best practice review examines four series of common primary care questions in laboratory medicine: (i) sodium abnormalities; (ii) faecal occult blood testing; (iii) warfarin management; and (iv) sputum cytology in diagnosis of bronchopulm
Autor:
K K, Hampton
Publikováno v:
International Journal of Clinical Practice. 57:424-427
We describe a case in which an elderly woman is hospitalised for acute medical illness and ask how this patient's risk of venous thromboembolism should be assessed and managed. Venous thromboembolism was previously regarded as a surgical problem, but
Autor:
K. K. Hampton
Publikováno v:
Hospital Medicine. 62:765-772
Venous thromboembolism remains an important cause of morbidity and mortality for surgical and non-surgical patients, and its pathophysiology in acutely ill, non-surgical patients is not well understood. The clinically silent nature of thromboembolism
Autor:
Martina E. Daly, K. K. Hampton, Kevin S Channer, M. D. Teare, Richard P. Steeds, S. A. Croft, Nilesh J. Samani
Publikováno v:
Circulation. 104:1459-1463
Background Glycoprotein (GP) VI plays a crucial role in platelet activation and aggregation. We investigated whether polymorphic variation at the GP VI locus confers an increased risk of myocardial infarction (MI). Methods and Results Coding and 5′